HERPES VIRUS (HHV 1) - ANVISA Registration 10287411089
Access comprehensive regulatory information for HERPES VIRUS (HHV 1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10287411089 and manufactured by CELL MARQUE CORPORATION. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including VIRCELL S.L., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10287411089
25351094219201524
30280358000186
Company Information
Dates and Status
Apr 20, 2015
VIGENTE
09/18/2025 19:00:01
HERPES VÍRUS (HHV 1)
Familia MAGLUMI HSV-1 de IgM (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513420
Apr 28, 2025
HERPES VÍRUS (HHV 1)
Micropartículas de HSV-1 IgM (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513349
Jan 13, 2025
HERPES VÍRUS (HHV 1)
Micropartículas de HSV-1 IgG (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513294
Sep 02, 2024
HERPES VÍRUS (HHV 1)
Família HSV-1 IgG
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
80943610204
Jul 08, 2024
HERPES VÍRUS (HHV 1)
Família Atellica IM Herpes-1 IgG (HSV1)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162480
Mar 04, 2024

